Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 501538200

IBL America Anti-Certolizumab pegol (Cimzia) ELISA

Supplier:  IBL America TM09035

Encompass_Preferred

The drug Certolizumab pegol (trade name Cimzia) is a tumor necrosis factor alpha (TNF) blocker and binds to human TNF with a KD of 90pM. Certolizumab pegol is a recombinant, humanized antibody Fab' fragment, with specificity for TNF, conjugated to an approximately 40kDa polyethylene glycol (PEG). The Fab' fragment is manufactured in E. coli and is subsequently subjected to purification and conjugation to PEG2MAL40K, to generate Certolizumab pegol. The ImmunoGuide Antibody to Certolizumab pegol ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug.Enzyme immunoassay for the semi-quantitative determination of free antibodies to Certolizumab pegol (CZP) in serum and plasma. For research use only - not for use in diagnostic procedures.

Catalog No. 50-153-8200


May include imposed supplier surcharges.
Only null left
Add to cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.